The Impact of Surfactants in Tailoring Nanostructured Lipid Carriers for Inhaled Levofloxacin
Abstract
Abstract Nanoparticles can enhance pulmonary delivery of antibiotics by modifying or targeting drug release, increasing drug stability, decreasing mucus entrapment, disrupting biofilms, and reaching the deep lung. Surfactants play a key role as coating agents for several nanoparticle types, modulating interfacial interactions with drugs and the environment. Specifically, levofloxacin (LV) inhalation can benefit from its loading into nanostructured lipid carriers (NLCs) for high drug entrapment, sustained release, and antimicrobial efficacy, but no studies have focused on the relevance of the surfactant type on its biological and physicochemical performance. Therefore, this study aimed to evaluate the impact of three nonionic surfactants─polysorbate 80 (P80), poloxamer 407 (P407), and poloxamer 188 (P188)─on the physicochemical and biological in vitro performance of LV-loaded NLCs. NLCs presented similar physicochemical properties, with average sizes of 100–200 nm, polydispersity 77%), and rounded-shape morphology. The P188 coating tends to have a prolonged release profile compared to the other formulations, but further studies should be conducted to confirm this tendency. All formulations preserved the antimicrobial activity of LV in vitro compared to the free LV against Klebsiella pneumoniae, Staphylococcus aureus, Burkholderia cepacia, and Haemophilus influenzae. Notably, P407 was the only surfactant able to maintain the biofilm inhibition of B. cepacia promoted by LV up…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.